<DOC>
	<DOCNO>NCT00198523</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence combination test agent , prednisolone acetate 1.0 % tobramycin 0.3 % ophthalmic suspension compare PredForte ( prednisolone acetate 1.0 % ) ophthalmic suspension . Bioequivalence measure compare aqueous humor concentration prednisolone acetate .</brief_summary>
	<brief_title>A Bioequivalence Study Tobramycin Prednisolone Acetate Compared PredForte</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Bilateral cataract surgery Avoid disallow medication throughout study Contraindications use test agent Known allergy sensitivity test agent component History steroid response follow topical administration corticosteroid eye Wore contact lenses 48 hour prior Visit 1 An intraocular pressure great 22 mmHg less 5 mmHg either eye Any significant illness could expect interfere study Used ophthalmic , topical systemic corticosteroid immunomodulator 7 day prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Cataract Extraction</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
	<keyword>Steroids</keyword>
</DOC>